PAMT vs PALI: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

PALI has stronger fundamentals based on our AI analysis.

PAMT
PAMT CORP
STRONG SELL
95%
Confidence
VS
PALI
PALISADE BIO, INC.
SELL
68%
Confidence

PAMT vs PALI Fundamental Comparison

Metric PAMT PALI
Revenue $598.1M $0.0
Net Income $-52.6M $-16.8M
Net Margin -8.8% N/A
ROE -25.0% -13.0%
ROA -7.5% -12.5%
Current Ratio 1.23x 28.95x
Debt/Equity 1.59x 0.00x
EPS $-2.48 $-0.30

Green = Better metric | Red = Weaker metric

View Full PAMT Analysis →
View Full PALI Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

PAMT vs AAPL PALI vs MSFT PAMT vs GOOGL PALI vs AMZN

PAMT vs PALI: Frequently Asked Questions

Is PAMT or PALI a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), PALI has stronger fundamentals. PAMT is rated STRONG SELL (95% confidence) while PALI is rated SELL (68% confidence). This is not investment advice.

How does PAMT compare to PALI fundamentally?

PAMT CORP has ROE of -25.0% vs PALISADE BIO, INC.'s -13.0%. Net margins are -8.8% vs N/A respectively.

Which stock pays higher dividends, PAMT or PALI?

PAMT has a dividend yield of N/A or no dividend while PALI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in PAMT or PALI for long term?

For long-term investing, consider that PAMT has STRONG SELL rating with 95% confidence, while PALI has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about PAMT vs PALI?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PAMT vs PALI, the AI consensus favors PALI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.